Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Merck
Medtronic
McKesson
AstraZeneca

Last Updated: November 27, 2022

CLINICAL TRIALS PROFILE FOR LACTULOSE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Lactulose

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00004796 ↗ Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis Completed Northwestern University Phase 2 1994-11-01 OBJECTIVES: I. Assess the effect of lactulose on the circadian rhythm of plasma melatonin in patients with subclinical hepatic encephalopathy. II. Assess the intrasubject variability of circadian melatonin levels and neuropsychological tests. III. Assess which elements of the neuropsychological test battery show the response to lactulose.
NCT00004796 ↗ Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis Completed National Center for Research Resources (NCRR) Phase 2 1994-11-01 OBJECTIVES: I. Assess the effect of lactulose on the circadian rhythm of plasma melatonin in patients with subclinical hepatic encephalopathy. II. Assess the intrasubject variability of circadian melatonin levels and neuropsychological tests. III. Assess which elements of the neuropsychological test battery show the response to lactulose.
NCT00133406 ↗ Long-term Impact and Intervention for Diarrhea in Brazil Unknown status National Institute of Allergy and Infectious Diseases (NIAID) Phase 3 2006-06-01 The primary objectives of this study are to determine the effect of 1 year supplementation of Vitamin A, Zinc, and Vitamin A plus Zinc compared to placebo on the Height for Age Z Score (HAZ) and the number of episodes of diarrhea and number of days of diarrhea at one year in children living in a Brazilian slum. Study participants will include 280 children ages 2 months to 8 years old, with a Height for Age Z score (HAZ) less than median for the Parque Universitario community, living in Brazilian favela. There is also a sub study to determine if ten days of glutamine delivered as an oral bolus improves the health of the digestive system.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Lactulose

Condition Name

Condition Name for Lactulose
Intervention Trials
Hepatic Encephalopathy 36
Liver Cirrhosis 13
Constipation 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Lactulose
Intervention Trials
Hepatic Encephalopathy 47
Brain Diseases 46
Liver Cirrhosis 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Lactulose

Trials by Country

Trials by Country for Lactulose
Location Trials
United States 138
China 19
India 18
United Kingdom 8
Brazil 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Lactulose
Location Trials
New York 11
California 10
Virginia 8
Texas 6
Massachusetts 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Lactulose

Clinical Trial Phase

Clinical Trial Phase for Lactulose
Clinical Trial Phase Trials
Phase 4 34
Phase 3 17
Phase 2/Phase 3 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Lactulose
Clinical Trial Phase Trials
Completed 69
Unknown status 24
Recruiting 20
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Lactulose

Sponsor Name

Sponsor Name for Lactulose
Sponsor Trials
Valeant Pharmaceuticals International, Inc. 9
Bausch Health Americas, Inc. 8
Institute of Liver and Biliary Sciences, India 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Lactulose
Sponsor Trials
Other 196
Industry 56
NIH 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Moodys
Boehringer Ingelheim
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.